Project Grant HT94252510674
Award Date
7/15/25
Completion Date
7/14/28
Dollars Obligated
$894K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This federal Project Grant award of $155,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Washington University in University City, Missouri. The award, effective from September 30, 2025 to September 29, 2027, will investigate the "Pathophysiologic Effects of Obesogenic Diet in Neurofibromatosis Type 1 and Impact on Tumor Formation." This research aims to transform healthcare for military service members,...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This Project Grant award from the Department of the Army Medical Command totals $894,263 to The Washington University for the period of September 1, 2022 through August 31, 2025. The award supports research under the Military Medical Research and Development program (CFDA 12.420) to further understanding of the pathogenesis and prognostication of malignant peripheral nerve sheath tumors (MPNSTs) associated with Neurofibromatosis type 1 (NF1). Under the award, The Washington University will...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $934,501 project grant to The Children's Hospital of Philadelphia Research Institute. The grant, titled "Developing Peptide-Centric CARs for NF1-Associated MPNST", will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research aims to develop innovative peptide-based chimeric antigen receptor (CAR) therapies...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
This Project Grant award, valued at $543,285.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the University of Washington will conduct research to develop new FDA-approved combination therapies for transforming the treatment of rhabdomyosarcoma, a rare...
This federal Project Grant award of $523,614.37, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research into the genetic mechanisms underlying schwannomatosis and other rare conditions. The University of Manchester, a prominent research institution in the United Kingdom, will conduct this 3-year research initiative, focusing on elucidating the disease-specific genetic factors that distinguish...
The federal Project Grant award, valued at $176,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the Sloan-Kettering Institute for Cancer Research in establishing a mouse model of myxoid/round cell liposarcoma with endogenous translocations. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on critical health...